3869 — Hospital of China Income Statement
0.000.00%
Last trade - 00:00
- HK$884.44m
- HK$1.56bn
- CNY1.43bn
- 36
- 81
- 21
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 411 | 399 | 520 | 1,143 | 1,428 |
Cost of Revenue | |||||
Gross Profit | 174 | 194 | 214 | 151 | 239 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 234 | 799 | 955 | 1,681 | 1,213 |
Operating Profit | 177 | -400 | -435 | -538 | 214 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 196 | -436 | -449 | -533 | 216 |
Provision for Income Taxes | |||||
Net Income After Taxes | 169 | -421 | -362 | -529 | 168 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 151 | -404 | -281 | -478 | 131 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 46.3 | -404 | -281 | -478 | 131 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.235 | 0.298 | 0.69 | -1.28 | 0.951 |
Dividends per Share |